Abstract
In this study we screened 3060 consecutive blood donors for an unbound iron-binding capacity level of <28 μM and then performed HFE mutation analysis in these subjects. Sixty-five of the 75 subjects with a low initial unbound iron-binding capacity (all had normal ferritin levels) came back and only 5 (8%) had a low fasting unbound iron-binding capacity. Mutational analysis revealed H63D heterozygosity in two of five subjects. Four of five subjects had liver biopsy indication and none had increased liver iron. HFE genotyping of 60 subjects with a low initial but normal fasting unbound iron-binding capacity revealed heterozygote H63D in seven (11.6%). No allelic variant of position 282 or 63 was found in three previously diagnosed patients with hereditary hemochromatosis. In conclusion, full phenotypic expression of hereditary hemochromatosis is very rare in Turkey. The absence of HFE mutations in three patients with hereditary hemochromatosis suggests that hereditary hemochromatosis in Turkey occurs without common HFE mutations.
Similar content being viewed by others
References
Olson KS, Ritter B, Rosen U, Heedman PA, Staugard F: Prevalence of iron overload in Central Sweden. Acta Med Scand 213:145-150, 1983
Olson KS, Eriksson K, Ritter B, Heedman PA: Screening for iron overload using transferrin saturation. Acta Med Scand 215:105-112, 1984
Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP: Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 318:1355-1362, 1988
Leggett BA, Halliday JW, Brown NN, Bryant S, Powell LW: Prevalence of haemochromatosis amongst asymptomatic Australians. Br J Haematol 74:525-530, 1990
Wiggers P, Dalhoj J, Kier H, Ring-Larsen H, Petersen PH, Blaabjerg O: Screening for haemochromatosis: prevalance among Danish blood donors. J Intern Med 230:265-270, 1991
Baer DM, Simons JL, Stables RL, Rumore GJ, Morton CJ: Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older. Am J Med 98:464-468, 1995
Smith BN, Kantrowitz W, Grace ND, Greenberg MS, Patton TJ, Ookubo R, Sorger K, Semeraro JG, Doyle JR, Cooper AG, Kamat BR, Maregni LM, Rand WM: Prevalence of hereditary hemochromatosis in a Massachusetts corporation: is Celtic origin a risk factor? Hepatology 25:1439-1446, 1997
Burt MJ, George PM, Upton JD, Collett JA, Frampton CM, Chapman TM, Walmsly TA, Chapman BA: The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut 43:830-836, 1998
Bassett ML, Halliday JW, Bryant S, Dent O, Powell LW: Screening for hemochromatosis. Ann NY Acad Sci 526:274-278, 1988
Olynyk JK, Cullen DJ, Aquilia S, Rossi E Summerville L, Powell LW: A population based study of clinical expression of the hemochromatosis gene. N Engl J Med 341:718-724, 1999
Adams PC, Kertesz AE, McLaren CE, Barr R, Bamford A, Chakrabarti S: Population screening for hemochromatosis. A comparison of unbound iron binding capacity, transferrin saturation, and C282Y genotyping in 5211 voluntary blood donors. Hepatology 31:1160-1164, 2000
Merryweather-Clarke AT, Pointon JJ, Sherman JD, Robson KJ: Global prevalence of putative hemochromatosis mutations. J Med Genet 34:275-278, 1997
Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Wolf RK: A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399-408, 1996
Jazwinska EC, Cullen LM, Busfield F, Pyper WR, Webb SI, Powell LW, Morris CP, Walsh TP: Haemochromatsosis and HLA-H. Nat Genet 14:249-251, 1996
Jouanolle AM, Gandon G, Jezequel P, Blayau M, Campion ML, Yaounq J, Mosser J, Fergelot P, Chauvel B, Bouric P, Carn G, Andrieux N, Gicquel I, Le Gall JY, David V: Haemochromatosis HLA-H. Nat Genet 14:251-252, 1996
The UK Haemochromatosis Consortium: A simple genetic test identifies 90% of UK patients with haemochromatosis. Gut 41:841-844, 1997
Adams PC, Chakrabarti S: Genotypic/phenotypic correlations in genetic hemochromatosis: evaluation of diagnostic criteria. Gastroenterology 114:319-323, 1998
Burke W, Thomson E, Khoury MJ, McDonnell SM, Pres N, Adams PC, Barton JC, Beutler E, Brittenham G, Buchanan A, Clayton EW, Cogswell ME, Meslin EM, Motulsky AG, Powell LW, Sigal E, Wilfond BS, Collins FS: Hereditary hemochromatosis: gene discovery and implications for population-based screening. JAMA 280:172-178, 1998
Moirand R, Jouanolle AM, Brissot P, Le Gall J, Deugnier Y, David V: Phenotypic expression of HFE mutations: a French study of 1110 unrelated iron-overloaded patients and relatives. Gastroenterology 116:372-377, 1999
Beutler E, Felitti V, Gelbart T, Ho N: The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann of Intern Med 133:329-337, 2000
Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Hutton RD, Napier JA, Worwood M: HFE mutations, iron deficiency and overload in 10 500 blood donors. Br J Haematol 114:474-484, 2001
Wurapa RK, Gordeuk VR, Brittenham GM, Khiyami A, Schecter GP, Edwards CO: primary iron overload in African Americans. Am J Med 101:9-18, 1996
Monaghan KG, Rybicki BA, Shurafa M, Feldman GL: Mutation analysis of the HFE gene associated with hereditary hemochromatosis in Africans Americans. Am J Hematol 58:213-217, 1998
Gordeuk VR, McLaren CE, Looker AC, Hasselblad V, Brittenham GM: Distribution of transferrin saturations in the African-American population. Blood 91:2175-2179, 1998
Carella M, D'Ambrossio L, Totara A, Grifa A, Valentino MA, Piperno A, Girelli D, Roetto A, Franco B, Gasparini P, Camaschella C: Mutation analysis of HLA-H gene in Italian hemochromatosis patients. Am Hum Genet 60:828-832, 1997
Piperno A, Sampietro M, Pietrangelo A, Arosio C, Lupica L, Montosi G, Vergani A, Fraquelli M, Girelli D, Pasquero P, Roetto A, Gasparini P, Fargion S, Conte D, Camaschella C: Heterogenity of hemochromatosis in Italy. Gastroenterology 114:996-1002, 1998
Pietrangelo A, Montosi G, Totaro A, Garyti C, Conte D, Cassanelli S, Fraquelli M, Sardini C, Vasta F, Gasparini P: Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene. N Eng J Med 341:725-732, 1999
Cullen LM, Summreville L, Glassick TV Crawford DH, Powell LW, Jazwinska EC: Neonatal screening for the haemochromatosis defect. Blood 90:4236-4237, 1997
Powell LW, Subramaniam VN, Yapp TR: Haemochromatosis in the new millennium. J Hepatol 32 (Supp 1):48-62, 1999
Yang Q, McDonnell SM, Khoury MJ, Cono J, Parrish RG: Hemochromatosis-associated mortality in the United states from 1979 to 1992: an analysis of multiple-cause mortality data. Ann Intern Med 129:946-953, 1998
Balan V, Baldus W, Fairbanks V, Michels V, Burritt M, Klee G: Screening for hemochromatosis: a cost-effectiveness study based on 12 258 patients. Gastroenterology 107:453-459, 1994
Phatak PD, Guzman G, Woll JE, Robeson A, Phelps CE: Cost-effectiveness of screening for hereditary hemochromatosis. Arch Intern Med 154:769-776, 1994
Adams PC, Gregor JC, Kertesz AE, Valberg LS: Screening blood donors for hereditary hemochromatosis: decision analysis based on a 30 year database. Gastroenterology 109: 177-188, 1995
Adams PC, Valberg LS: Screening blood donors for hereditary hemochromatosis: decision analysis model comparing genotyping to phenotyping. Am J Gastroenterol 94:1593-1600, 1999
Basset ML, Leggett BA, Halliday JW, Webb S; Powell LW: Analysis of the cost of population screening for hemochromatosis using biochemical and genetic markers. J Hepatol 27:517-524, 1997
Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA: Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta 245:139-200, 1996
Adams PC: Population screening for haemochromatosis. Gut 46:301-303, 2000
Gurel S: Genetic hemochromatosis: a report of two cases. Turk J Gastroenterol 9:385-387, 1998
Jouanolle AM, Fergelot P, Gandom G, Yaouanq J, Le Gall JY, David V: A candidate gene for hemochromatosis: frequency of the C282Y and H63D. Hum Genet 100:544-547, 1997
Scheuer PJ, Williams R, Muir AR: Hepatic pathology in relatives of patients with haemochromatosis. J Pathol Bacteriol 84:53-64, 1962
Aguilar-Martinez P, Bismuth M, Picot MC, Thelcide C, Paageaux GP, Blanc F, Blanc P, Schved JF, Larrey D: Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause? Gut 48:836-842, 2001
Rosmorduc O, Poupon R, Nion I, Wendum D, Feder J, Bereziat G, Hermelin B: Differential HFE allele expression in hemochromatois heterozygotes. Gastroenterology 119:1075-1086, 2000
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bozkaya, H., Bektas, M., Metin, O. et al. Screening for Hemochromatosis in Turkey. Dig Dis Sci 49, 444–449 (2004). https://doi.org/10.1023/B:DDAS.0000020500.26184.ce
Issue Date:
DOI: https://doi.org/10.1023/B:DDAS.0000020500.26184.ce